Oxford, United Kingdom

Matthew Salter

This inventor holds 1 USPTO granted patent. Top assignee: Oxford Biodynamics Plc. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew Salter. Retrieved from https://idiyas.com/inventor/matthew-salter

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Matthew Salter

Introduction

Matthew Salter is an accomplished inventor based in Oxford, GB. He has made significant contributions to the field of genetics and neurodegenerative diseases. His work focuses on understanding chromosome interactions and their implications for conditions such as amyotrophic lateral sclerosis (ALS) and Huntington's disease.

Latest Patents

Matthew Salter holds a patent titled "Detection of chromosome interactions as indicative of amyotrophic lateral sclerosis." This innovative process analyzes chromosome regions and interactions that are related to ALS and Huntington's disease. His research aims to provide insights that could lead to better diagnostic and therapeutic strategies for these debilitating conditions.

Career Highlights

Matthew is currently employed at Oxford Biodynamics Plc, a company known for its pioneering work in epigenetics and biomarker discovery. His role at the company allows him to apply his expertise in chromosome analysis to real-world applications, contributing to advancements in medical research.

Collaborations

Matthew collaborates with notable colleagues, including Alexandre Akoulitchev and Aroul Selvam Ramadass. These partnerships enhance the research efforts at Oxford Biodynamics Plc and foster innovation in the field.

Conclusion

Matthew Salter's work exemplifies the intersection of innovation and medical research. His contributions to understanding chromosome interactions are paving the way for future advancements in the treatment of neurodegenerative diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…